20 May 2013
Keywords: eisai, lilly, team, up, antiulcerant, eli, usa
Article | 02 August 1993
Eisai and Eli Lilly of the USA have entered into a codevelopment and
comarketing agreement for a proton pump inhibitor, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 August 1993
9 August 1993
26 July 1993
© 2013 thepharmaletter.com